The great thing about the SAARDS trials is, if there’re not successful it won’t effect the SP IMO, because most investors here were in way before the BOD smartly changed direction. Now, if they are successful and we get fast tracked it will put IHL in the map, and the FOMO will come into effect. So very smart move on the BOD behalf. Very nervous but exciting times ahead.
Ann: IHL commences IHL-675 (ARDS) animal study, page-38
-
- There are more pages in this discussion • 75 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)